These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1578168)

  • 21. Faecal alpha 1-antitrypsin concentration in the diagnosis and management of patients with pouchitis.
    Boerr LA; Sambuelli AM; Sugai E; Graziano A; Valero J; Kogan Z; Bai J
    Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):129-33. PubMed ID: 7712304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of fecal alpha 1-antitrypsin excretion for assessment of inflammatory bowel diseases.
    Becker K; Frieling T; Häussinger D
    Eur J Med Res; 1998 Feb; 3(1-2):65-70. PubMed ID: 9512970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliability and usefulness of random fecal alpha 1-antitrypsin concentration: further simplification of the method.
    Magazzù G; Jacono G; Di Pasquale G; Sferlazzas C; Tedeschi A; Santoro S; Nibali SC; Musso F; Balsamo V
    J Pediatr Gastroenterol Nutr; 1985 Jun; 4(3):402-7. PubMed ID: 3874949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal clearance of alpha 1-antitrypsin. A sensitive method for the detection of protein-losing enteropathy.
    Florent C; L'Hirondel C; Desmazures C; Aymes C; Bernier JJ
    Gastroenterology; 1981 Oct; 81(4):777-80. PubMed ID: 6973500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Initial clinical experiences with a simplified analytic method for fecal alpha-1-antitrypsin].
    Fischbach W; Deubel M; Boege F; Mössner J
    Z Gastroenterol; 1991 Dec; 29(12):650-4. PubMed ID: 1771947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reassessment of faecal alpha-1-antitrypsin excretion for use as screening test for intestinal protein loss.
    Quigley EM; Ross IN; Haeney MR; Holbrook IB; Marsh MN
    J Clin Pathol; 1987 Jan; 40(1):61-6. PubMed ID: 3493263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
    Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
    Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary lupus-associated protein-losing enteropathy.
    Sunheimer RL; Finck C; Mortazavi S; McMahon C; Pincus MR
    Ann Clin Lab Sci; 1994; 24(3):239-42. PubMed ID: 8048795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein losing enteropathy in critically ill adult patients with burns: a preliminary report.
    Venkatesh B; Gough J; Ralston DR; Muller M; Pegg S
    Intensive Care Med; 2004 Jan; 30(1):162-6. PubMed ID: 14634725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal alpha1--antitrypsin in healthy and intestinal-disorder Thai children.
    Tangsilsat D; Atamasirikul K; Treepongkaruna S; Bed SN; Sumritsopak R; Kunakorn M
    J Med Assoc Thai; 2007 Jul; 90(7):1317-22. PubMed ID: 17710971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individual fecal alpha 1-antitrypsin excretion reflects clinical activity in Crohn's disease but not in ulcerative colitis.
    Becker K; Berger M; Niederau C; Frieling T
    Hepatogastroenterology; 1999; 46(28):2309-14. PubMed ID: 10521988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Graft-versus-host disease of the intestine: a protein losing enteropathy characterized by fecal alpha 1-antitrypsin.
    Weisdorf SA; Salati LM; Longsdorf JA; Ramsay NK; Sharp HL
    Gastroenterology; 1983 Nov; 85(5):1076-81. PubMed ID: 6352387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is portal hypertension associated with protein-losing enteropathy?
    Georgopoulos P; Mowat C; McMillan DC; Kingstone K; Ghosh S; Stanley AJ
    J Gastroenterol Hepatol; 2005 Jan; 20(1):103-7. PubMed ID: 15610454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein-losing enteropathy: case illustrations and clinical review.
    Umar SB; DiBaise JK
    Am J Gastroenterol; 2010 Jan; 105(1):43-9; quiz 50. PubMed ID: 19789526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simplified determination of intestinal protein excretion based on alpha 1-antitrypsin clearance.
    Karbach U; Singe CC; Ewe K
    Z Gastroenterol; 1988 Mar; 26(3):169-73. PubMed ID: 3261475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of oral budesonide in adolescents and adults with protein-losing enteropathy after the Fontan operation.
    John AS; Driscoll DJ; Warnes CA; Phillips SD; Cetta F
    Ann Thorac Surg; 2011 Oct; 92(4):1451-6. PubMed ID: 21784410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of autoimmunity in schistosomiasis.
    Abbas MM; Abdel Kader S
    J Egypt Soc Parasitol; 1993 Apr; 23(1):289-96. PubMed ID: 8482877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors affecting C3 in intestinal schistosomiasis.
    Hussein MM; Ahmed MM; Fayed M
    J Egypt Soc Parasitol; 1993 Dec; 23(3):769-73. PubMed ID: 8308353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
    Sugi K; Saitoh O; Hirata I; Katsu K
    Am J Gastroenterol; 1996 May; 91(5):927-34. PubMed ID: 8633583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fecal alpha 1-antitrypsin clearance in protein-losing enteropathies in pediatrics].
    Heffes Nahmod LA; Litwin N; Guastavino E
    Acta Gastroenterol Latinoam; 1987; 17(2):97-103. PubMed ID: 3502057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.